Rasmus Juul Kildemoes

7PUBLICATIONS
18CO-AUTHORS
PharmacogenomicsInfant and child healthPharmaceutical delivery technologiesGene expression (incl. microarray and other genome-wide approaches)Nutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 29, 2026
Model-based somapacitan dosing and IGF-I response in children born SGA or with ISS, Noonan or Turner syndromes.

|Sep 13, 2024
Somapacitan in Children Born SGA: 52-Week Efficacy, Safety, and IGF-I Response Results From the Phase 2 REAL5 Study.

Anders Juul, Philippe Backeljauw, Michael Højby

|Jul 05, 2024
Investigating the Bioavailability and Insulin-like Growth Factor-I Release of Two Different Strengths of Somapacitan: A Randomised, Double-Blind Crossover Trial.

Sarah Louise Dombernowsky, Birgitte Bentz Damholt, Michael Højby Rasmussen

|Oct 11, 2023
Model-Based Analysis of IGF-I Response, Dosing, and Monitoring for Once-Weekly Somapacitan in Children With GH Deficiency.

Rasmus J Kildemoes, Philippe F Backeljauw, Michael Højby

|May 06, 2022
Dose-exposure-IGF-I response of once-weekly somapacitan in adults with GH deficiency.

Rasmus Juul Kildemoes, Christian Hollensen, Beverly M K Biller

|May 10, 2021
Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials.

Rune V Overgaard, Andrea Navarria, Steen H Ingwersen

Pageof 2

Frequent Collaborators

4 joint publications

Michael Højby Rasmussen

2 joint publications

Jun Mori

2 joint publications

Philippe Backeljauw

2 joint publications

Agnès Linglart